A phase I clinical trial enrolled its first patient only two days after US Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months.
A phase I clinical trial enrolled its first patient only two days after US Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months.